Lyra Therapeutics (LYRA) Institutional Ownership $9.31 +0.41 (+4.61%) Closing price 04:00 PM EasternExtended Trading$9.21 -0.10 (-1.07%) As of 04:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Lyra Therapeutics (NASDAQ:LYRA)CurrentInstitutional OwnershipPercentage95.62%Number ofInstitutional Buyers(last 12 months)7TotalInstitutional Inflows(last 12 months)$27.88MNumber ofInstitutional Sellers(last 12 months)5TotalInstitutional Outflows(last 12 months)$13.79M Get LYRA Insider Trade Alerts Want to know when executives and insiders are buying or selling Lyra Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data LYRA Institutional Buying and Selling by Quarter Lyra Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails6/27/2025Goldman Sachs Group Inc.370,194$47K0.0%-33.4%27.834% 5/16/2025Goldman Sachs Group Inc.370,194$47K0.0%-33.4%0.559% 2/17/2025Two Sigma Investments LP209,997$43K0.0%-25.7%0.321% 2/17/2025Two Sigma Advisers LP385,500$80K0.0%-16.3%0.589% 2/17/2025BNP Paribas Financial Markets244,920$51K0.0%N/A0.374% 2/14/2025Samsara BioCapital LLC1,965,689$406K0.1%-29.3%3.003% 2/14/2025Northern Trust Corp286,310$59K0.0%+56.2%0.437% 2/13/2025ADAR1 Capital Management LLC533,200$110K0.0%N/A0.815% 2/12/2025Geode Capital Management LLC885,966$183K0.0%+15.3%1.353% 2/12/2025JPMorgan Chase & Co.156,442$32K0.0%+161.8%0.239% Get the Latest News and Ratings for LYRA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lyra Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/15/2024State Street Corp488,720$126K0.0%+88.1%0.747% 8/6/2024Acadian Asset Management LLC985,631$271K0.0%N/A1.617% 7/12/2024Rosalind Advisors Inc.1,034,773$286K0.2%-9.6%1.697% 5/17/2024Ikarian Capital LLC1,056,829$6.57M0.7%-15.7%1.733% 5/10/2024Vanguard Group Inc.1,481,481$9.22M0.0%+38.3%2.430% 4/25/2024Rosalind Advisors Inc.1,144,524$7.12M6.7%-39.4%1.916% 2/15/2024Parkman Healthcare Partners LLC754,885$3.96M0.6%+20.8%1.436% 2/14/2024Vestal Point Capital LP3,000,000$15.72M1.7%N/A5.708% 2/13/2024Armistice Capital LLC1,088,000$5.70M0.1%-29.8%2.070% 2/7/2024Jump Financial LLC16,737$88K0.0%N/A0.032% 1/25/2024Heritage Wealth Management Inc. Texas10,000$52K0.0%N/A0.019% 12/6/2023Citigroup Inc.67,677$265K0.0%N/A0.129% 11/15/2023Armistice Capital LLC1,550,000$6.06M0.1%-61.4%2.949% 11/14/2023Prescott Group Capital Management L.L.C.30,000$117K0.0%N/A0.057% 10/24/2023Bank of New York Mellon Corp18,621$73K0.0%N/A0.038% 8/24/2023Perceptive Advisors LLC12,757,562$52.43M1.5%+39.5%25.747% 8/14/2023Samsara BioCapital LLC2,780,261$11.43M2.0%+56.4%8.733% 8/14/2023Pura Vida Investments LLC1,413,242$5.72M0.8%-29.2%4.439% 8/10/2023Letko Brosseau & Associates Inc.31,900$131K0.0%N/A0.100% 2/15/2023Nantahala Capital Management LLC2,220,830$6.97M0.5%-1.1%6.977% 2/14/2023Pura Vida Investments LLC2,157,298$6.77M0.3%-14.1%6.778% 11/15/2022Pura Vida Investments LLC2,510,302$12.58M0.7%-2.6%7.888% 11/14/2022Boothbay Fund Management LLC34,721$174K0.0%-9.5%0.109% 11/10/2022Nantahala Capital Management LLC2,245,830$11.25M0.7%-5.2%17.262% 8/16/2022Pura Vida Investments LLC2,576,196$14.56M0.8%+394.9%19.802% 8/16/2022CVI Holdings LLC60,822$344K0.0%N/A0.468% 8/15/2022Nantahala Capital Management LLC2,369,668$13.39M0.7%N/A18.214% 8/12/2022Ensign Peak Advisors Inc56,229$318K0.0%+43.6%0.432% 8/12/2022Ikarian Capital LLC347,338$1.96M0.4%-17.8%2.670% 5/16/2022Clearline Capital LP119,924$482K0.1%+84.9%0.922% Trump’s Exec Order #14154 could be a “Millionaire-Maker” (Ad)Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape. For the moment, you can watch this interview free of charge – just click here.2/14/2022Clearline Capital LP64,862$283K0.0%N/A0.499% 2/14/2022Soleus Capital Management L.P.10,000$44K0.0%-95.4%0.077% 2/11/2022Pentwater Capital Management LP71,313$311K0.0%+122.8%0.548% 11/16/2021Two Sigma Advisers LP58,000$529K0.0%+31.8%0.446% 11/15/2021Pura Vida Investments LLC533,417$4.87M0.1%-1.7%4.103% 11/15/2021Marshall Wace LLP12,457$114K0.0%-35.5%0.096% 11/9/2021BlackRock Inc.17,818$163K0.0%-11.4%0.137% 11/4/2021Close Asset Management Ltd7,000$64K0.0%N/A0.054% 8/25/2021Marshall Wace LLP19,321$155K0.0%-58.8%0.149% 8/18/2021Ikarian Capital LLC624,684$5.02M0.4%-20.0%4.805% 8/17/2021Walleye Capital LLC19,093$153K0.0%N/A0.147% 8/17/2021Millennium Management LLC155,135$1.25M0.0%N/A1.193% 8/17/2021Bridgeway Capital Management LLC41,900$336K0.0%-14.5%0.322% 8/16/2021Tibra Equities Europe Ltd40,000$321K0.1%N/A0.308% 8/16/2021Marshall Wace LLP19,321$155K0.0%-58.8%0.149% 8/13/2021Geode Capital Management LLC36,102$289K0.0%-60.0%0.278% 8/13/2021Vanguard Group Inc.220,029$1.77M0.0%+3.8%1.692% 8/12/2021Trexquant Investment LP11,610$93K0.0%N/A0.089% 8/12/2021Ergoteles LLC31,000$249K0.0%N/A0.238% 8/11/2021Deutsche Bank AG76,441$614K0.0%-5.4%0.588% 8/11/2021Susquehanna International Group LLP21,529$173K0.0%N/A0.166% 8/2/2021Advisor Group Holdings Inc.4,434$36K0.0%-89.6%0.034% 5/18/2021Morgan Stanley107,217$1.24M0.0%+655.0%0.825% 5/17/2021Nuveen Asset Management LLC17,913$208K0.0%N/A0.138% 5/17/2021Ikarian Capital LLC780,728$9.05M0.3%-4.2%6.005% 5/13/2021Bank of New York Mellon Corp15,036$174K0.0%-22.7%0.116% 5/12/2021Northern Trust Corp64,451$746K0.0%-5.2%0.497% 5/12/2021Geode Capital Management LLC90,281$1.05M0.0%+31.8%0.696% 5/12/2021JPMorgan Chase & Co.147,400$1.71M0.0%-22.8%1.137% 5/7/2021BlackRock Inc.348,394$4.04M0.0%+31.9%2.688% (Data available from 1/1/2016 forward) LYRA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of LYRA shares? During the previous two years, 25 institutional investors and hedge funds held shares of Lyra Therapeutics. The most heavily invested institutionals were Perceptive Advisors LLC ($52.43M), Vestal Point Capital LP ($15.72M), Vanguard Group Inc. ($9.22M), Ikarian Capital LLC ($6.57M), Pura Vida Investments LLC ($5.72M), Armistice Capital LLC ($5.70M), and Parkman Healthcare Partners LLC ($3.96M).Learn more on Lyra Therapeutics' institutional investors. What percentage of Lyra Therapeutics' stock is owned by institutional investors? 95.62% of Lyra Therapeutics' stock is owned by institutional investors. Learn more on LYRA's institutional investor holdings. Which institutional investors have been buying Lyra Therapeutics' stock? Of the 18 institutional investors that purchased Lyra Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Perceptive Advisors LLC ($3.61M), Vestal Point Capital LP ($3M), Samsara BioCapital LLC ($1.00M), Acadian Asset Management LLC ($985.63K), ADAR1 Capital Management LLC ($533.20K), Vanguard Group Inc. ($410.02K), and BNP Paribas Financial Markets ($244.92K). How much institutional buying is happening at Lyra Therapeutics? Institutional investors have bought a total of 2,309,936 shares in the last 24 months. This purchase volume represents approximately $27.88M in transactions. Which of Lyra Therapeutics' major shareholders have been selling company stock? The following institutional investors have sold Lyra Therapeutics stock in the last 24 months: Samsara BioCapital LLC ($814.57K), Goldman Sachs Group Inc. ($370.63K), Rosalind Advisors Inc. ($109.75K), Two Sigma Advisers LP ($74.80K), and Two Sigma Investments LP ($72.55K). How much institutional selling is happening at Lyra Therapeutics? Institutional investors have sold a total of 1,442,301 shares in the last 24 months. This volume of shares sold represents approximately $13.79M in transactions. Related Companies SURG Institutional Ownership HYPR Institutional Ownership MDAI Institutional Ownership APT Institutional Ownership ICCM Institutional Ownership CTCX Institutional Ownership DXR Institutional Ownership NEPH Institutional Ownership MODD Institutional Ownership SPAI Institutional Ownership This page (NASDAQ:LYRA) was last updated on 7/2/2025 by MarketBeat.com Staff From Our PartnersSomething very strange is happening...What a "Mar-a-Lago Accord" could mean for the U.S. dollar While protests dominate the news... hardly anyone...Stansberry Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored“E.I.”- The biggest prediction of my career?One expert predicts that E.I. could see over 200,000% growth... But you need to move fast...Behind the Markets | SponsoredDalio heeds Buffett’s warning… [$319 million stake in gold]Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profita...Golden Portfolio | Sponsored379 passengers walked away from thisElon Musk just wrote a $51 million check to back this material’s next phase… Because it’s not just saving l...True Market Insiders | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lyra Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lyra Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LYRA Stock Alerts